Clinical Trial: The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors

U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07651020) titled 'The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors' on June 11.

Brief Summary: Here's a polished version of the text:

"This project involves patients with high-expression LRRC15 malignant tumors who are either clinically suspected of or diagnosed with pancreatic cancer, breast cancer, lung cancer, ovarian cancer, head and neck tumors, colorectal cancer, melanoma, etc., as well as healthy volunteers. Using a targeted LRRC15-specific SPECT imaging agent, SPECT/CT imaging is performed to achieve the following objectives:

For malignant tumor patients:

To support disease diagnosis and staging. Diagnos...